During the past decade, Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Pierre Fabre Medicament" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Sarcoma Alliance for Research through Collaboration (SARC)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie" are "Melanoma" (4 trials), "Ovarian Cancer" (2 trials), "Non-small Cell Lung Cancer" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Soft Tissue Sarcoma" (1 trials). Many other conditions were trialed in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie" in a lesser frequency.

Most popular intervention types in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie" are "Drug" (7 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Placebo" (1 trials), "Avelumab" (1 trials), "Cobimetinib" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie has several departments that took part in Clinical trials: "Centrum Onkologii Instytut im. M.Sklodowskiej-Curie; Klinika Ginekologii Onkologicznej" - 2 trials, "Centrum Onkologii, Instytut im. M. Sklodowskiej-Curie, Oddzial w Krakowie, Apteka Szpitalna" - 2 trials